Attitudes toward biomarker disclosure in the setting of preclinical AD trials among racial and ethnic groups
Our findings suggest race and ethnicity are associated with willingness to undergo biomarker testing and learn results, both generally and in preclinical Alzheimer's disease trials.
Authors
- Josh D. Grill
- Kristin Harkins (ORCID: https://orcid.org/0000-0001-5360-1043)
- Megan Witbracht (ORCID: https://orcid.org/0009-0003-0307-3184)
- Crystal M. Glover (ORCID: https://orcid.org/0000-0002-1430-7463)
- Christina M. Magana‐Ramirez (ORCID: https://orcid.org/0000-0003-0133-1875)
- Daniel L Gillen
- Jason Karlawish
Institutions
- University of California, Irvine (US)
- UC Irvine Health (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70858_103566
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00